那当初的发行价谁定的_老虎社区_美港股上老虎

2021-12-20

那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":693969177,"tweetId":"693969177","gmtCreate":1639961446517,"gmtModify":1639965490635,"author":{"id":3477051193551003,"authorId":3477051193551003,"authorIdStr":"3477051193551003","name":"卷子爸","avatar":"https://static.tigerbbs.com/3fec18b558225c9a74bfbe72db9d2218","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。</p></body></html>","htmlText":"<html><head></head><body><p>那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。</p></body></html>","text":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/693969177","repostId":2192904375,"repostType":2,"repost":{"id":"2192904375","pubTimestamp":1639960816,"share":"https://www.laohu8.com/m/news/2192904375?lang=&edition=full","pubTime":"2021-12-20 08:40","market":"us","language":"zh","title":"瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2192904375","media":"智通财经","summary":"智通财经APP获悉，瑞银发布研究报告称，首予鹰瞳科技“买入”评级，目标价75.20港元。视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/UBS\">瑞银</a>发布研究报告称，首予<a href=\"https://laohu8.com/S/90050\">鹰瞳科技</a>(02251)“买入”评级，目标价75.20港元。 </p><p>视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。</p><p>据悉，公司拥有强大的数据优势、丰富的产品管线以及多元的商业化销售网络。 \n长期来看，基于2030年视网膜影像AI市场规模可达340亿元的预测，如果鹰瞳科技持续成功地拓展更多的商业化渠道和客户，完成各项关键节点事件并超出预期，证明其执行力和更清晰的成长路径后，从DCF估值模型来看，鹰瞳科技股价的上升空间可达196.00港元。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 08:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/624957.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，瑞银发布研究报告称，首予鹰瞳科技(02251)“买入”评级，目标价75.20港元。 视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。据悉，公司拥有强大的数据优势、丰富的产品管线以及多元的商业化销售网络。 \n长期来看，基于2030年视网膜影像AI...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/624957.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/d2a986280a0d0ac6d75b62fd1fec8874","relate_stocks":{"02251":"鹰瞳科技-B"},"source_url":"http://www.zhitongcaijing.com/content/detail/624957.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192904375","content_text":"智通财经APP获悉，瑞银发布研究报告称，首予鹰瞳科技(02251)“买入”评级，目标价75.20港元。 视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。据悉，公司拥有强大的数据优势、丰富的产品管线以及多元的商业化销售网络。 \n长期来看，基于2030年视网膜影像AI市场规模可达340亿元的预测，如果鹰瞳科技持续成功地拓展更多的商业化渠道和客户，完成各项关键节点事件并超出预期，证明其执行力和更清晰的成长路径后，从DCF估值模型来看，鹰瞳科技股价的上升空间可达196.00港元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":705,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":51,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/693969177"}